Copyright Reports & Markets. All rights reserved.

Global Fexofenadine Hydrochloride Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Fexofenadine Hydrochloride Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 180mg
    • 1.3.3 120mg
    • 1.3.4 60mg
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Fexofenadine Hydrochloride Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Fexofenadine Hydrochloride Tablets Market Size & Forecast
    • 1.5.1 Global Fexofenadine Hydrochloride Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Fexofenadine Hydrochloride Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Fexofenadine Hydrochloride Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 OPELLA HEALTHCARE FRANCE SAS
    • 2.1.1 OPELLA HEALTHCARE FRANCE SAS Details
    • 2.1.2 OPELLA HEALTHCARE FRANCE SAS Major Business
    • 2.1.3 OPELLA HEALTHCARE FRANCE SAS Fexofenadine Hydrochloride Tablets Product and Services
    • 2.1.4 OPELLA HEALTHCARE FRANCE SAS Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 OPELLA HEALTHCARE FRANCE SAS Recent Developments/Updates
  • 2.2 Sun Pharmaceutical Industries Ltd.
    • 2.2.1 Sun Pharmaceutical Industries Ltd. Details
    • 2.2.2 Sun Pharmaceutical Industries Ltd. Major Business
    • 2.2.3 Sun Pharmaceutical Industries Ltd. Fexofenadine Hydrochloride Tablets Product and Services
    • 2.2.4 Sun Pharmaceutical Industries Ltd. Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Fexofenadine Hydrochloride Tablets Product and Services
    • 2.3.4 Sanofi Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 Teva Pharmaceuticals
    • 2.4.1 Teva Pharmaceuticals Details
    • 2.4.2 Teva Pharmaceuticals Major Business
    • 2.4.3 Teva Pharmaceuticals Fexofenadine Hydrochloride Tablets Product and Services
    • 2.4.4 Teva Pharmaceuticals Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva Pharmaceuticals Recent Developments/Updates
  • 2.5 Viatris
    • 2.5.1 Viatris Details
    • 2.5.2 Viatris Major Business
    • 2.5.3 Viatris Fexofenadine Hydrochloride Tablets Product and Services
    • 2.5.4 Viatris Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Viatris Recent Developments/Updates
  • 2.6 Sandoz
    • 2.6.1 Sandoz Details
    • 2.6.2 Sandoz Major Business
    • 2.6.3 Sandoz Fexofenadine Hydrochloride Tablets Product and Services
    • 2.6.4 Sandoz Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sandoz Recent Developments/Updates
  • 2.7 Dr. Reddy's Laboratories
    • 2.7.1 Dr. Reddy's Laboratories Details
    • 2.7.2 Dr. Reddy's Laboratories Major Business
    • 2.7.3 Dr. Reddy's Laboratories Fexofenadine Hydrochloride Tablets Product and Services
    • 2.7.4 Dr. Reddy's Laboratories Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Dr. Reddy's Laboratories Recent Developments/Updates
  • 2.8 Sun Pharmaceutical Industries
    • 2.8.1 Sun Pharmaceutical Industries Details
    • 2.8.2 Sun Pharmaceutical Industries Major Business
    • 2.8.3 Sun Pharmaceutical Industries Fexofenadine Hydrochloride Tablets Product and Services
    • 2.8.4 Sun Pharmaceutical Industries Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sun Pharmaceutical Industries Recent Developments/Updates
  • 2.9 CSPC Pharmaceutical Group
    • 2.9.1 CSPC Pharmaceutical Group Details
    • 2.9.2 CSPC Pharmaceutical Group Major Business
    • 2.9.3 CSPC Pharmaceutical Group Fexofenadine Hydrochloride Tablets Product and Services
    • 2.9.4 CSPC Pharmaceutical Group Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CSPC Pharmaceutical Group Recent Developments/Updates
  • 2.10 Lunan Pharmaceutical Group
    • 2.10.1 Lunan Pharmaceutical Group Details
    • 2.10.2 Lunan Pharmaceutical Group Major Business
    • 2.10.3 Lunan Pharmaceutical Group Fexofenadine Hydrochloride Tablets Product and Services
    • 2.10.4 Lunan Pharmaceutical Group Fexofenadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Lunan Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Fexofenadine Hydrochloride Tablets by Manufacturer

  • 3.1 Global Fexofenadine Hydrochloride Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Fexofenadine Hydrochloride Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Fexofenadine Hydrochloride Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Fexofenadine Hydrochloride Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Fexofenadine Hydrochloride Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Fexofenadine Hydrochloride Tablets Manufacturer Market Share in 2025
  • 3.5 Fexofenadine Hydrochloride Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Fexofenadine Hydrochloride Tablets Market: Region Footprint
    • 3.5.2 Fexofenadine Hydrochloride Tablets Market: Company Product Type Footprint
    • 3.5.3 Fexofenadine Hydrochloride Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Fexofenadine Hydrochloride Tablets Market Size by Region
    • 4.1.1 Global Fexofenadine Hydrochloride Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Fexofenadine Hydrochloride Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Fexofenadine Hydrochloride Tablets Average Price by Region (2021-2032)
  • 4.2 North America Fexofenadine Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.3 Europe Fexofenadine Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Fexofenadine Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.5 South America Fexofenadine Hydrochloride Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Fexofenadine Hydrochloride Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Fexofenadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Fexofenadine Hydrochloride Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Fexofenadine Hydrochloride Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Fexofenadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Fexofenadine Hydrochloride Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Fexofenadine Hydrochloride Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Fexofenadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Fexofenadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Fexofenadine Hydrochloride Tablets Market Size by Country
    • 7.3.1 North America Fexofenadine Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Fexofenadine Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Fexofenadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Fexofenadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Fexofenadine Hydrochloride Tablets Market Size by Country
    • 8.3.1 Europe Fexofenadine Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Fexofenadine Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Fexofenadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Fexofenadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Fexofenadine Hydrochloride Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Fexofenadine Hydrochloride Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Fexofenadine Hydrochloride Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Fexofenadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Fexofenadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Fexofenadine Hydrochloride Tablets Market Size by Country
    • 10.3.1 South America Fexofenadine Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Fexofenadine Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Fexofenadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Fexofenadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Fexofenadine Hydrochloride Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Fexofenadine Hydrochloride Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Fexofenadine Hydrochloride Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Fexofenadine Hydrochloride Tablets Market Drivers
  • 12.2 Fexofenadine Hydrochloride Tablets Market Restraints
  • 12.3 Fexofenadine Hydrochloride Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Fexofenadine Hydrochloride Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Fexofenadine Hydrochloride Tablets
  • 13.3 Fexofenadine Hydrochloride Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Fexofenadine Hydrochloride Tablets Typical Distributors
  • 14.3 Fexofenadine Hydrochloride Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Fexofenadine Hydrochloride Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Fexofenadine Hydrochloride Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Fexofenadine Hydrochloride Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Fexofenadine Hydrochloride Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Fexofenadine Hydrochloride Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Fexofenadine Hydrochloride Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Fexofenadine Hydrochloride Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Fexofenadine Hydrochloride Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include OPELLA HEALTHCARE FRANCE SAS, Sun Pharmaceutical Industries Ltd., Sanofi, Teva Pharmaceuticals, Viatris, Sandoz, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, CSPC Pharmaceutical Group, Lunan Pharmaceutical Group, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Fexofenadine Hydrochloride Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    180mg
    120mg
    60mg
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    OPELLA HEALTHCARE FRANCE SAS
    Sun Pharmaceutical Industries Ltd.
    Sanofi
    Teva Pharmaceuticals
    Viatris
    Sandoz
    Dr. Reddy's Laboratories
    Sun Pharmaceutical Industries
    CSPC Pharmaceutical Group
    Lunan Pharmaceutical Group
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Fexofenadine Hydrochloride Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Fexofenadine Hydrochloride Tablets, with price, sales quantity, revenue, and global market share of Fexofenadine Hydrochloride Tablets from 2021 to 2026.
    Chapter 3, the Fexofenadine Hydrochloride Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Fexofenadine Hydrochloride Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Fexofenadine Hydrochloride Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Fexofenadine Hydrochloride Tablets.
    Chapter 14 and 15, to describe Fexofenadine Hydrochloride Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now